J&J Coronavirus Vaccine Study Paused After Participant Suffers Unexplained Illness – By Danielle Ong (IB Times) / Oct 12 2020
- J&J temporarily suspended its COVID-19 vaccine trial after a patient caught an illness
- The company refused to provide details about the case, citing privacy concerns
- This is the second time a major coronavirus vaccine study was put on hold due to adverse events
Johnson & Johnson has temporarily suspended its coronavirus vaccine study after a participant suffered an unexplained illness.
According to Stat News, the 60,000-patient clinical trial met the criteria for a “pausing rule.” This means the online system they use to enroll patients in the study has been closed. An independent committee responsible for watching over the safety of patients in the trial will be convened.
Johnson & Johnson confirmed the document obtained by Stat News indicated the study was on pause. However, the company refused to provide further details and said it was due to “an unexplained illness in a study participant.”
“We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,” the company said in a statement.
Continue to article> https://www.ibtimes.com/jj-coronavirus-vaccine-study-paused-after-participant-suffers-unexplained-illness-3061074
